Stay updated on Cabozantinib in Japanese Advanced Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Japanese Advanced Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib in Japanese Advanced Renal Cell Carcinoma Clinical Trial page
- CheckyesterdayChange DetectedA sitewide NIH notice was added above the ClinicalTrials.gov navigation, announcing a transition in terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check8 days agoChange DetectedThe footer’s site revision marker changed from v3.7.1 to v3.7.2; the page still displays a 403 error.SummaryDifference0.2%

- Check15 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check35 days agoChange DetectedThe page now shows a 403 Forbidden error, indicating access is blocked, instead of displaying the study record content. This blocks viewing the study details and navigation, and does not represent a substantive update to the page's information.SummaryDifference18%

- Check56 days agoChange DetectedThe page footer now displays Revision: v3.6.6, reflecting a platform update. There are no changes to trial details, eligibility criteria, or results indicated by this update.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page footer now shows Revision: v3.6.5 instead of v3.6.4. This indicates a software update to the site, with no changes to the study content or data.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib in Japanese Advanced Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Japanese Advanced Renal Cell Carcinoma Clinical Trial page.